BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31064660)

  • 21. Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management.
    Panzuto F; Massironi S; Partelli S; Campana D; Rinzivillo M; Invernizzi P; Andreasi V; Lamberti G; Falconi M
    Surg Oncol; 2020 Dec; 35():141-148. PubMed ID: 32877883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastroenteropancreatic neuroendocrine tumors: Role of surgery.
    Sauvanet A
    Ann Endocrinol (Paris); 2019 Jun; 80(3):175-181. PubMed ID: 31079831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptomatic presentation as a predictor of recurrence in gastroenteropancreatic neuroendocrine tumors: A single institution experience over 15 years.
    Baptiste GG; Postlewait LM; Ethun CG; Le N; McInnis MR; Russell MC; Winer JH; Kooby DA; Staley CA; Maithel SK; Cardona K
    J Surg Oncol; 2016 Aug; 114(2):163-9. PubMed ID: 27157897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETs.
    Prinzi N; Raimondi A; Maccauro M; Milione M; Garanzini E; Torchio M; Corti F; Nichetti F; Lo Russo G; Giacomelli L; Mazzaferro V; Di Bartolomeo M; Seregni E; de Braud F; Pusceddu S
    Future Oncol; 2019 Sep; 15(26):3015-3024. PubMed ID: 31424273
    [No Abstract]   [Full Text] [Related]  

  • 27. Intervention in gastro-enteropancreatic neuroendocrine tumours.
    Baudin E; Planchard D; Scoazec JY; Guigay J; Dromain C; Hadoux J; Debaere T; Elias D; Ducreux M
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):855-65. PubMed ID: 23582924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit.
    Barrett JR; Rendell V; Pokrzywa C; Lopez-Aguiar AG; Cannon J; Poultsides GA; Rocha F; Crown A; Beal E; Michael Pawlik T; Fields R; Panni RZ; Smith P; Idrees K; Cho C; Beems M; Maithel S; Weber S; Erik Abbott D
    J Surg Oncol; 2020 Jun; 121(7):1067-1073. PubMed ID: 32153032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties.
    Kankava K; Maisonneuve P; Mangogna A; Centonze G; Cattaneo L; Prinzi N; Pusceddu S; Fazio N; Pisa E; Di Domenico S; Bertani E; Mazzaferro V; Albertelli M; Grillo F; Milione M
    J Neuroendocrinol; 2021 Aug; 33(8):e13000. PubMed ID: 34268808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms.
    Attili F; Capurso G; Vanella G; Fuccio L; Delle Fave G; Costamagna G; Larghi A
    Dig Liver Dis; 2014 Jan; 46(1):9-17. PubMed ID: 23731843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical management of neuroendocrine tumors.
    Tamburrino D; Spoletini G; Partelli S; Muffatti F; Adamenko O; Crippa S; Falconi M
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):93-102. PubMed ID: 26971846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
    Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
    Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An 11-year retrospective study: clinicopathological and survival analysis of gastro-entero-pancreatic neuroendocrine neoplasm.
    Liu H; Xie R; Zhao Z; Xu D; Yang K; Ding M; Tan D; Liao W; Han X; Zhang J; Shen D; Yuan J; Xu Z; Fei J
    Medicine (Baltimore); 2020 Aug; 99(33):e21682. PubMed ID: 32872039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).
    Orgera G; Krokidis M; Cappucci M; Gourtsoyianni S; Tipaldi MA; Hatzidakis A; Rebonato A; Rossi M
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):13-24. PubMed ID: 25366087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathological Landscape of Precursor Lesions of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms.
    Biancotti R; Dal Pozzo CA; Parente P; Businello G; Angerilli V; Realdon S; Savarino EV; Farinati F; Milanetto AC; Pasquali C; Vettor R; Grillo F; Pennelli G; Luchini C; Mastracci L; Vanoli A; Milione M; Galuppini F; Fassan M
    Dig Dis; 2023; 41(1):34-48. PubMed ID: 35816999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodality management, recurrence patterns, and long-term outcome of gastroenteropancreatic neuroendocrine neoplasms: Progress over 17 years.
    Desai GS; Pande P; Chhabra V; Shah RC; Jagannath P
    Indian J Gastroenterol; 2019 Oct; 38(5):399-410. PubMed ID: 31802438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma.
    Ooki A; Osumi H; Fukuda K; Yamaguchi K
    Cancer Metastasis Rev; 2023 Sep; 42(3):1021-1054. PubMed ID: 37422534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rare case with synchronous gastric gastrointestinal stromal tumor, pancreatic neuroendocrine tumor, and uterine leiomyoma.
    Arabadzhieva E; Yonkov A; Bonev S; Bulanov D; Taneva I; Vlahova A; Dikov T; Dimitrova V
    World J Surg Oncol; 2016 Nov; 14(1):287. PubMed ID: 27846844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gastroenteropancreatic neuroendocrine tumors : (GEP-NENs)].
    Sebesta C; Feichter A; Selimi F
    Wien Med Wochenschr; 2023 Jun; 173(9-10):221-226. PubMed ID: 36512264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Principles of diagnosis and management of neuroendocrine tumours.
    Raphael MJ; Chan DL; Law C; Singh S
    CMAJ; 2017 Mar; 189(10):E398-E404. PubMed ID: 28385820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.